• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工通气期间使用潘龙(溴化潘库溴铵)的患者出现的神经肌肉并发症。

Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation.

作者信息

Op de Coul A A, Lambregts P C, Koeman J, van Puyenbroek M J, Ter Laak H J, Gabreëls-Festen A A

出版信息

Clin Neurol Neurosurg. 1985;87(1):17-22. doi: 10.1016/0303-8467(85)90060-5.

DOI:10.1016/0303-8467(85)90060-5
PMID:3987137
Abstract

This paper reports on 12 patients in a 3-year period (from 1st July 1980 to 1st July 1983) who were treated with artificial ventilation and with the muscle relaxant pancuronium bromide (Pavulon), over a period of 6 days or longer. After discontinuation of this drug these patients developed severe tetraparesis with areflexia, sometimes combined with disturbances of the extraocular and facial muscles and diffuse muscular atrophy, without sensory disturbances. Seven patients recovered completely after 2-5 months, two made an incomplete recovery and three died due to the primary disease. It is suggested that these neuromuscular complications were caused by prolonged high-dosage Pavulon treatment in combination with renal and hepatic disturbances and/or the use of aminoglucosides.

摘要

本文报告了在3年期间(从1980年7月1日至1983年7月1日)接受人工通气及肌肉松弛剂潘库溴铵(巴夫龙)治疗6天或更长时间的12例患者。停用该药后,这些患者出现了严重的四肢轻瘫伴反射消失,有时合并眼外肌和面肌功能障碍及弥漫性肌肉萎缩,无感觉障碍。7例患者在2至5个月后完全康复,2例恢复不完全,3例因原发病死亡。提示这些神经肌肉并发症是由长期高剂量使用潘库溴铵治疗,合并肾、肝损害和/或使用氨基糖苷类药物所致。

相似文献

1
Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation.人工通气期间使用潘龙(溴化潘库溴铵)的患者出现的神经肌肉并发症。
Clin Neurol Neurosurg. 1985;87(1):17-22. doi: 10.1016/0303-8467(85)90060-5.
2
[Tetraparesis in an infant after prolonged administration of pancuronium].[泮库溴铵长期给药后婴儿出现的四肢瘫痪]
Ann Fr Anesth Reanim. 1995;14(5):426-8. doi: 10.1016/s0750-7658(05)80396-x.
3
Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination.接受泮库溴铵治疗的重症监护病房患者的神经肌肉疾病。在一组7例患者和2例散发病例中出现,并进行了电生理和组织学检查。
Chest. 1994 Jul;106(1):210-20. doi: 10.1378/chest.106.1.210.
4
[Influence of pavulon on facial nerve monitoring during middle ear-mastoid operation].
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1999 Nov;13(11):490-2.
5
Skeletal muscle growth failure induced in premature newborn infants by prolonged pancuronium treatment.长时间使用泮库溴铵治疗导致早产儿骨骼肌生长衰竭。
J Pediatr. 1986 Nov;109(5):883-6. doi: 10.1016/s0022-3476(86)80719-3.
6
[Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].[阿曲库铵、维库溴铵或泮库溴铵预箭毒化后琥珀酰胆碱的效应概况]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 Jun;31(5):304-8. doi: 10.1055/s-2007-995925.
7
[A case of motor neuropathy with pyramidal sign due to prolonged administration of high dose of pancuronium bromide (Myoblock)].[一例因长期大剂量使用潘库溴铵(米库氯铵)导致伴有锥体束征的运动神经病病例]
Rinsho Shinkeigaku. 1993 Jun;33(6):620-4.
8
Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade.一名接受神经肌肉阻滞的哮喘持续状态通气患者的废用性萎缩。
Crit Care Med. 1987 Aug;15(8):795-6. doi: 10.1097/00003246-198708000-00019.
9
Critical illness polyneuromyopathy after artificial respiration.人工呼吸后发生的危重病性多神经肌肉病
Clin Neurol Neurosurg. 1991;93(1):27-33. doi: 10.1016/0303-8467(91)90005-a.
10
[Polyneuropathy and myopathy in oxalosis].[草酸osis中的多发性神经病和肌病]
Nervenarzt. 1988 Jul;59(7):422-5.

引用本文的文献

1
Critical Illness Polyneuropathy: Eluding Intensivists Since Its Discovery.重症疾病多发性神经病:自发现以来一直让重症监护医生感到困惑。
Neurocrit Care. 2024 Oct 21. doi: 10.1007/s12028-024-02152-6.
2
Intensive care unit-acquired weakness - preventive, and therapeutic aspects; future directions and special focus on lung transplantation.重症监护病房获得性肌无力——预防与治疗方面;未来方向及对肺移植的特别关注
World J Clin Cases. 2024 Jul 6;12(19):3665-3670. doi: 10.12998/wjcc.v12.i19.3665.
3
Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
疾病虚弱、多发性神经病和肌病:诊断、治疗和长期预后。
Crit Care. 2023 Nov 13;27(1):439. doi: 10.1186/s13054-023-04676-3.
4
Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review.危重病性多发性神经病和肌病患者的恢复和长期功能结局:范围综述。
BMC Neurol. 2022 Feb 11;22(1):50. doi: 10.1186/s12883-022-02570-z.
5
Muscle Regeneration after Critical Illness: Are Satellite Cells the Answer?危重症后的肌肉再生:卫星细胞是答案吗?
Am J Respir Crit Care Med. 2016 Oct 1;194(7):780-782. doi: 10.1164/rccm.201603-0633ED.
6
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.病弱者:危重症患者的神经病变/肌病
Physiol Rev. 2015 Jul;95(3):1025-109. doi: 10.1152/physrev.00028.2014.
7
Myofibrillar protein and gene expression in acute quadriplegic myopathy.急性四肢瘫痪性肌病中的肌原纤维蛋白和基因表达。
J Neurol Sci. 2009 Oct 15;285(1-2):28-38. doi: 10.1016/j.jns.2009.04.041. Epub 2009 Jun 6.
8
Periods of systemic partial hypoxia induces apoptosis and inflammation in rat skeletal muscle.
Mol Cell Biochem. 2007 Aug;302(1-2):51-8. doi: 10.1007/s11010-007-9424-7. Epub 2007 Feb 24.
9
Diagnosis and management of critical illness polyneuropathy and critical illness myopathy.危重病性多发性神经病和危重病性肌病的诊断和治疗。
Curr Treat Options Neurol. 2007 Mar;9(2):85-92. doi: 10.1007/s11940-007-0034-1.
10
Approach to neuromuscular disorders in the intensive care unit.重症监护病房中神经肌肉疾病的处理方法
Neurocrit Care. 2005;3(3):195-212. doi: 10.1385/NCC:3:3:195.